Yannick Allanore

Délégation Paris 5 — France

Medicine · Health Sciences

95h-index41.5kcitations982works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Systemic Sclerosis and Related Diseases(674), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(253), Inflammatory Myopathies and Dermatomyositis(146), Dermatologic Treatments and Research(143), Mast cells and histamine(106)

Publications979 total

Impact du diabète mellitus sur l’évolution de la sclérodermie systémique : résultats d’une étude multicentrique internationale
Revue du Rhumatisme·2025
Distinct Effects of Complement <scp> <i>C4A</i> </scp> and <scp> <i>C4B</i> </scp> Copy Numbers in Systemic Sclerosis Serological and Clinical Subtypes
Arthritis & Rheumatology·2025Open Access
Exploiting a unified vascular framework to predict organ-specific complications and accomplish disease modification in systemic sclerosis
The Lancet Rheumatology·2025· 2 cited
Integrin-mediated inhibition of CCN1 attenuates angiogenesis and joint damage in experimental rheumatoid arthritis
2025Open Access
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease
European Respiratory Journal·2025· 8 citedOpen Access
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)
Annals of the Rheumatic Diseases·2025· 17 citedOpen Access
Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study
npj Digital Medicine·2025· 1 citedOpen Access
Treatment recommendations for the systemic pharmacological treatment of systemic sclerosis digital ulcers: Results from the World Scleroderma Foundation Ad Hoc Committee
Journal of Scleroderma and Related Disorders·2025· 3 citedOpen Access
Assessing the <i>MUC5B</i> promoter variant in a large cohort of systemic sclerosis-associated interstitial lung disease
RMD Open·2025· 1 citedOpen Access
Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study
Lara D. Veeken·2025· 2 citedOpen Access
Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort
Lara D. Veeken·2025· 3 cited
OP0153 PATHOGENIC ROLE OF MUCOSAL-ASSOCIATED INVARIANT T CELLS IN RHEUMATOID ARTHRITIS
Annals of the Rheumatic Diseases·2025Open Access
OP0242 UNMET NEEDS OF ADOLESCENTS AND YOUNG ADULTS WITH JUVENILE IDIOPATHIC ARTHRITIS: A SYSTEMATIC REVIEW
Annals of the Rheumatic Diseases·2025Open Access
POS0652 SAFETY AND EFFICACY OF TOCILIZUMAB IN SYSTEMIC SCLEROSIS: A MULTICENTER FRENCH-ITALIAN RETROSPECTIVE STUDY
Annals of the Rheumatic Diseases·2025
ABS0068 SUBCLINICAL LOSS OF LUNG VOLUMES IN VERY EARLY SYSTEMIC SCLEROSIS: EVIDENCE FROM TWO INDEPENDENT COHORTS IN EUSTAR
Annals of the Rheumatic Diseases·2025Open Access
POS0671 CARDIAC BIOMARKERS AND PREDICTION OF MAJOR CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: RESULTS FROM THE ESPOIR COHORT
Annals of the Rheumatic Diseases·2025Open Access
POS0728 DECIPHERING SYNOVIAL FLUID IMMUNE DYSREGULATION IN RHEUMATOID ARTHRITIS THROUGH CYTOKINE PROFILING AND SINGLE-CELL TRANSCRIPTOMICS
Annals of the Rheumatic Diseases·2025Open Access
OP0216 DISEASE CHARACTERISTICS OF ANTI-CENTROMERE POSITIVE SYSTEMIC SCLEROSIS PATIENTS AND RISK FACTORS FOR ORGAN INVOLVEMENT: DATA FROM THE EUSTAR COHORT
Annals of the Rheumatic Diseases·2025Open Access
Mucosal‐Associated Invariant T Cells in Rheumatic Diseases
Arthritis & Rheumatology·2025· 1 citedOpen Access
Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) ‘Ad hoc committee’
Journal of Scleroderma and Related Disorders·2025· 2 citedOpen Access
page 1 of 49Next →

Frequent Co-authors

Marco Matucci‐Cerinic(22), Oliver Distler(21), Gabriela Riemekasten(15), Christopher P. Denton(15), Ulf Müller‐Ladner(15), Jérôme Avouac(14), É. Hachulla(14), László Czirják(12), Ulrich A. Walker(12), Gabriele Valentini(11), André Kahan(11), Dinesh Khanna(10), Daniel E. Furst(9), Jacob M. van Laar(9), Janet Pope(9), Otylia Kowal‐Bielecka(8), Jean Sibilia(8), Alan Tyndall(7), Virginia Steen(7), Leland W.K. Chung(7)